SISTEMA INTEGRAL DE INFORMACIÓN ACADÉMICA - PÚBLICO

Erika Ruiz-Garcia
(Autor externo)

Obras con ISBN:0
Documentos en revistas:14
Colaboraciones en Tesis:0
Patentes:0
Obras con ISBN:No hay obras de este autor.
Documentos en revistas:
1.- The Anti-proliferative Effects of Anandamide and Oleamide in Glioblastoma Cell Lines Recruit Mitochondrial and PPAR-? Receptor Modulation (2026)
 
2.- Validation of the Mexican version of the EORTC QLQ-CR29 in patients with colorectal cancer (2024)
 
3.- Age as a Predictor of Overall Survival in Colorectal Cancer (2024)
 
4.- Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population (2023)
 
5.- Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in Mexico (2022)
 
6.- Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results (2021)
 
7.- SOX9 is associated with advanced T-stages of clinical stage II colon cancer in young Mexican patients (2021)
 
8.- Oleamide Induces Cell Death in Glioblastoma RG2 Cells by a Cannabinoid Receptor-Independent Mechanism (2020)
 
9.- A novel protective role for microRNA-3135b in Golgi apparatus fragmentation induced by chemotherapy via GOLPH3/AKT1/mTOR axis in colorectal cancer cells (2020)
 
10.- miR-145-5p is associated with pathological complete response to neoadjuvant chemotherapy and impairs cell proliferation by targeting TGF beta R2 in breast cancer (2019)
 
11.- let-7d-3p is associated with apoptosis and response to neoadjuvant chemotherapy in ovarian cancer (2018)
 
12.- A microRNA signature associated with pathological complete response to a novel neoadjuvant therapy regimen in triple negative breast cancer (2018)
 
13.- Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic Melanoma (2017)
 
14.- ECOG is as independent predictor of the response to chemotherapy, overall survival and progression-free survival in carcinoma of unknown primary site (2017)
 
Colaboraciones en Tesis:No hay tesis de este autor.
Patentes:No hay patentes de este autor.